E. Cavalier Et Al. , "Assessing the status of European laboratories in evaluating biomarkers for chronic kidney diseases (CKD) and recommendations for improvement: Insights from the 2022 EFLM Task Group on CKD survey," Clinical Chemistry and Laboratory Medicine , vol.62, no.2, pp.253-261, 2024
Cavalier, E. Et Al. 2024. Assessing the status of European laboratories in evaluating biomarkers for chronic kidney diseases (CKD) and recommendations for improvement: Insights from the 2022 EFLM Task Group on CKD survey. Clinical Chemistry and Laboratory Medicine , vol.62, no.2 , 253-261.
Cavalier, E., Makris, K., Portakal, O., Nikler, A., Datta, P., Zima, T., ... Delanaye, P.(2024). Assessing the status of European laboratories in evaluating biomarkers for chronic kidney diseases (CKD) and recommendations for improvement: Insights from the 2022 EFLM Task Group on CKD survey. Clinical Chemistry and Laboratory Medicine , vol.62, no.2, 253-261.
Cavalier, Etienne Et Al. "Assessing the status of European laboratories in evaluating biomarkers for chronic kidney diseases (CKD) and recommendations for improvement: Insights from the 2022 EFLM Task Group on CKD survey," Clinical Chemistry and Laboratory Medicine , vol.62, no.2, 253-261, 2024
Cavalier, Etienne Et Al. "Assessing the status of European laboratories in evaluating biomarkers for chronic kidney diseases (CKD) and recommendations for improvement: Insights from the 2022 EFLM Task Group on CKD survey." Clinical Chemistry and Laboratory Medicine , vol.62, no.2, pp.253-261, 2024
Cavalier, E. Et Al. (2024) . "Assessing the status of European laboratories in evaluating biomarkers for chronic kidney diseases (CKD) and recommendations for improvement: Insights from the 2022 EFLM Task Group on CKD survey." Clinical Chemistry and Laboratory Medicine , vol.62, no.2, pp.253-261.
@article{article, author={Etienne Cavalier Et Al. }, title={Assessing the status of European laboratories in evaluating biomarkers for chronic kidney diseases (CKD) and recommendations for improvement: Insights from the 2022 EFLM Task Group on CKD survey}, journal={Clinical Chemistry and Laboratory Medicine}, year=2024, pages={253-261} }